The proportion of EPCAM+ to EPCAM− tumour cells was unchanged after Rhoj deletion (Fig. 2h and Extended Data Fig. 3f), showing that RHOJ does not control EMT per se. This evidence concerns the gene EPCAM and neoplasm.